Is the US prepared to deal with another pandemic or widespread health crisis?

[1][2][3][4][5]No, the US is not fully prepared for another pandemic or widespread health crisis, though it has made meaningful improvements in some areas since COVID-19. Significant gaps in leadership consistency, sustained funding, coordination, health system capacity, and recent policy shifts leave it vulnerable. Experts, bipartisan commissions, GAO reports, and government assessments consistently highlight that while material stockpiles and surveillance have advanced, systemic weaknesses persist, and the traditional “panic-and-neglect” cycle risks eroding gains.[2]

Key Improvements Since COVID-19

•Strategic National Stockpile (SNS) and medical countermeasures: The SNS was substantially restocked. Compared to pre-pandemic levels, it holds far more N95 respirators (reported ~70x), gloves, isolation gowns, ventilators, and other PPE/supplies. It has supported responses to mpox (vaccines/therapeutics deployed) and H5N1 (millions of PPE pieces distributed in 2024). BARDA continues advancing vaccines, therapeutics, and platforms (e.g., mRNA adaptable for threats like bird flu, with stockpiles of relevant vaccines).[1]

•Surveillance and detection: Dramatic expansion of electronic case reporting (from under 200 healthcare facilities pre-COVID to over 45,000–48,000 by 2024), syndromic surveillance covering most emergency departments, wastewater monitoring, and better data-sharing frameworks. CDC’s Center for Forecasting and Outbreak Analytics provides risk assessments.[6]

•Coordination structures: The White House Office of Pandemic Preparedness and Response Policy (OPPR) was established in 2023 (via congressional mandate) to lead/coordinate pandemic efforts. Updated National Biodefense Strategy, Global Health Security Strategy (2024), and frameworks like the Public Health Emergency Preparedness (PHEP) program incorporate COVID lessons. Investments strengthened domestic manufacturing and global health security (e.g., >$3B since 2020, support for the Pandemic Fund).[7]

•Other: Broader testing/treatment access lessons applied; equity-focused efforts during COVID recovery; ASPR leads medical/public health preparedness/response. The US historically ranks at or near the top of the Global Health Security Index (e.g., ~83.5/100 overall in prior editions, #1).[8]

Biden-era roadmaps (released around the 2025 transition) documented these steps and left playbooks for successors, emphasizing vaccination scale-up successes, testing distribution (hundreds of millions of free tests), and equity.[9]

Persistent and Emerging Gaps

•Leadership and coordination: The Bipartisan Commission on Biodefense’s 2024 National Blueprint for Biodefense states the nation “remains dangerously vulnerable,” with fragmented efforts across 15+ departments/agencies. It calls for stronger, sustained White House leadership (e.g., codifying National Security Advisor roles, a Deputy for biodefense) and a quadrennial strategy review. Only the White House can effectively direct cross-agency action. GAO has repeatedly flagged HHS leadership/coordination of public health emergencies as high-risk, citing recurring issues in mpox (e.g., vaccine/test access challenges for jurisdictions, communication problems) that mirrored COVID failures. HHS lacks a fully coordinated, department-wide after-action process incorporating external stakeholders.[2][3]

•Funding and the panic-neglect cycle: Public health preparedness funding often surges during crises then drops. PHEMCE multiyear budgets project large needs (e.g., ~$67B over FY2025–2029 for medical countermeasures across ASPR/BARDA, SNS, NIH, CDC, FDA), with multi-billion-dollar shortfalls under flat funding. SNS sustainment, advanced development, domestic manufacturing, and stockpiling face gaps. Public health workforce shortages remain severe (estimates of needing tens of thousands more workers). Temporary COVID supplemental funds built capacity that is hard to maintain.[4][10]

•Health system and supply chain resilience: Hospitals and public health departments face capacity limits, staffing burnout, and inequities. Supply chains for PPE, medicines, and components remain vulnerable (though onshoring efforts exist). Indoor air quality/pathogen transmission reduction in buildings is under-addressed. Antimicrobial resistance and zoonotic threats (e.g., ongoing H5N1 in animals/humans) strain systems.[11]

•Recent erosions (post-2024/2025): Reports indicate periods of understaffing or emptiness in OPPR; NIAID strategic plans de-emphasizing biodefense, emerging infectious diseases, and pandemic preparedness; program cuts or wind-downs (e.g., certain mRNA investments, Centers for Research in Emerging Infectious Diseases); database discontinuations at CDC; tighter gain-of-function research restrictions that some experts say could hinder preparedness research; and funding pressures. Critics (including former officials) argue this dismantles prior progress and heightens risk. ASPR continues operations (e.g., responses to H5N1, disasters), but multiyear budgets highlight needs far exceeding baseline appropriations.[5][12]

•Trust, equity, and implementation: Public trust in institutions/public health eroded. Disparities in outcomes (racial/ethnic, rural/urban, socioeconomic) persist. Many GAO COVID-related recommendations remain unimplemented. Political polarization can hinder unified response.[13]

Expert and Official Consensus

The Bipartisan Commission, GAO, NEJM commentaries, BMJ analyses, Stimson Center, and others conclude the US is not adequately prepared—better in stockpiles/tech than 2019, but still exposed to worse outcomes from a more lethal/transmissible threat due to incomplete lesson-learning, funding instability, and leadership gaps. COVID exposed that high GHS Index rankings did not guarantee strong performance. Ongoing threats (H5N1 spillover, mpox clades, other high-consequence pathogens) test systems and reveal shortfalls.[11][14]

Bottom line: Material readiness (stockpiles, platforms, surveillance) has improved, and frameworks exist, but the US lacks the sustained political will, stable multi-year funding, seamless coordination, robust workforce/health system surge capacity, and consistent high-level leadership needed for a severe crisis. Preparedness is a continuous process, not a one-time fix; without addressing the gaps (as urged in bipartisan reports), another major event could again overwhelm systems, with high human and economic costs. Progress is possible with renewed commitment, as the tools and knowledge largely exist.

Citations (14)

1archives.govGovernment
https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/
Backs: “[[1]](https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/)”
2biodefensecommission.orgNonprofits and think tanks
https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/
Backs: “[[2]](https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/)”
3gao.govGovernment
https://www.gao.gov/products/gao-24-106276
Backs: “[[3]](https://www.gao.gov/products/gao-24-106276)”
4center-forward.orgNonprofits and think tanks
https://center-forward.org/basic/pandemic-preparedness-strengthening-the-u-s-response-framework-2/
Backs: “[[4]](https://center-forward.org/basic/pandemic-preparedness-strengthening-the-u-s-response-framework-2/)”
5the-scientist.comNot yet classified
https://www.the-scientist.com/niaid-moves-away-from-biodefense-experts-are-worried-75109
Backs: “[[5]](https://www.the-scientist.com/niaid-moves-away-from-biodefense-experts-are-worried-75109)”
6cdc.govGovernment
https://www.cdc.gov/washington/testimony/2024/t20241114.htm
Backs: “CDC’s Center for Forecasting and Outbreak Analytics provides risk assessments.”
7ucsb.eduAcademic
https://www.presidency.ucsb.edu/documents/fact-sheet-biden-harris-administration-releases-global-health-security-annual-report
Backs: “Investments strengthened domestic manufacturing and global health security (e.g., >$3B since 2020, support for the Pandemic Fund).”
8ghsindex.orgNot yet classified
https://ghsindex.org/country/united-states/
Backs: “The US historically ranks at or near the top of the Global Health Security Index (e.g., ~83.5/100 overall in prior editions, #1).”
9apnews.comNews and mediaquality 1.00
https://apnews.com/article/pandemic-preparedness-trump-biden-192518a8e1414cf40bafefdc2bf1f5ca
Backs: “Biden-era roadmaps (released around the 2025 transition) documented these steps and left playbooks for successors, emphasizing vaccination scale-up successes, testing distribution (hundreds of millions of free tests), and equity.”
10aspr.govGovernment
https://www.aspr.gov/news-updates/newsroom/2026-07/PHEMCE-Multiyear-Budget-July2026
Backs: “Temporary COVID supplemental funds built capacity that is hard to maintain.”
11nejm.orgAcademic
https://www.nejm.org/doi/full/10.1056/NEJMp2406427
Backs: “Antimicrobial resistance and zoonotic threats (e.g., ongoing H5N1 in animals/humans) strain systems.”
12notus.orgNot yet classified
https://www.notus.org/health-science/white-house-pandemic-preparedness
Backs: “ASPR continues operations (e.g., responses to H5N1, disasters), but multiyear budgets highlight needs far exceeding baseline appropriations.”
13stimson.orgNonprofits and think tanks
https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/
Backs: “Many GAO COVID-related recommendations remain unimplemented. Political polarization can hinder unified response.”
14bmj.comAcademic
https://www.bmj.com/content/384/bmj.q332
Backs: “Ongoing threats (H5N1 spillover, mpox clades, other high-consequence pathogens) test systems and reveal shortfalls.”